Antigen-Specific Memory B-cell Responses to Enterotoxigenic Escherichia coli Infection in Bangladeshi Adults

PLoS Neglected Tropical Diseases

Volumn 8, Issue 4, 2014, Pages

  Alam, Mohammad Murshid ^a   Aktar, Amena ^a   Afrin, Sadia ^a   Rahman, Mohammad Arif ^a   Aktar, Sarmin ^a   Uddin, Taher ^a   Rahman, M Arifur ^a   Mahbuba, Deena Al ^a   Chowdhury, Fahima ^a   Khan, Ashraful Islam ^a   Bhuiyan, Taufiqur Rahman ^a   Begum, Yasmin Ara ^a   Ryan, Edward T ^b,c,d   Calderwood, Stephen B ^b,c   Svennerholm, Ann Mari ^e   Qadri, Firdausi ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; ENTEROTOXIN; EPITOPE; HORSERADISH PEROXIDASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KEYHOLE LIMPET HEMOCYANIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; BANGLADESH; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; SOMATIC HYPERMUTATION; STEREOMICROSCOPY; VERNER MORRISON SYNDROME;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL TOXINS; BANGLADESH; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; FIMBRIAE PROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MALE;

EID: 84901252525     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002822     Document Type: Article

References (46)

1. Wenneras C, Erling V, (2004) Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. J Health Popul Nutr 22: 370-382.
2. WHO (2009) Enterotoxigenic Escherichia coli (ETEC). http://www.who.int/vaccine_research/diseases/diarrhoeal/en/index4.html.
3. Qadri F, Svennerholm AM, Faruque AS, Sack RB, (2005) Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 18: 465-483.
4. Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N, (2005) Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea. J Travel Med 12: 102-107.
5. Chowdhury F, Rahman MA, Begum YA, Khan AI, Faruque AS, et al. (2011) Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh. PLoS Negl Trop Dis 5: e999.
6. Gaastra W, Svennerholm AM, (1996) Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol 4: 444-452.
7. Jansson L, Tobias J, Jarefjall C, Lebens M, Svennerholm AM, et al. (2009) Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Escherichia coli. PLoS One 4: e4487.
8. Jansson L, Tobias J, Lebens M, Svennerholm AM, Teneberg S, (2006) The major subunit, CfaB, of colonization factor antigen i from enterotoxigenic Escherichia coli is a glycosphingolipid binding protein. Infect Immun 74: 3488-3497.
9. Sanchez J, Holmgren J, (2005) Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr Opin Immunol 17: 388-398.
10. Ahren CM, Svennerholm AM, (1982) Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens. Infect Immun 38: 74-79.
11. Levine MM, (1990) Modern vaccines. Enteric infections. Lancet 335: 958-961.
12. Qadri F, Ahmed F, Ahmed T, Svennerholm AM, (2006) Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children. Infect Immun 74: 4512-4518.
13. Svennerholm AM, Vidal YL, Holmgren J, McConnell MM, Rowe B, (1988) Role of PCF8775 antigen and its coli surface subcomponents for colonization, disease, and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits. Infect Immun 56: 523-528.
14. Svennerholm AM, Wenneras C, Holmgren J, McConnell MM, Rowe B, (1990) Roles of different coli surface antigens of colonization factor antigen II in colonization by and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits. Infect Immun 58: 341-346.
15. Tobias J, Svennerholm AM, (2012) Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates. Appl Microbiol Biotechnol 93: 2291-2300.
16. Anantha RP, McVeigh AL, Lee LH, Agnew MK, Cassels FJ, et al. (2004) Evolutionary and functional relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli. Infect Immun 72: 7190-7201.
17. Harris AM, Chowdhury F, Begum YA, Khan AI, Faruque AS, et al. (2008) Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am J Trop Med Hyg 79: 708-714.
18. Tobias J, Svennerholm AM, Holmgren J, Lebens M, (2010) Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines. Appl Microbiol Biotechnol 87: 1355-1365.
19. McConnell MM, Chart H, Rowe B, (1989) Antigenic homology within human enterotoxigenic Escherichia coli fimbrial colonization factor antigens: CFA/I, coli-surface-associated antigens (CS)1, CS2, CS4 and CS17. FEMS Microbiol Lett 52: 105-108.
20. Rudin A, McConnell MM, Svennerholm AM, (1994) Monoclonal antibodies against enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) that cross-react immunologically with heterologous CFAs. Infect Immun 62: 4339-4346.
21. Rudin A, Wiklund G, Wenneras C, Qadri F, (1997) Infection with colonization factor antigen I-expressing enterotoxigenic Escherichia coli boosts antibody responses against heterologous colonization factors in primed subjects. Epidemiol Infect 119: 391-393.
22. Qadri F, Ahmed T, Ahmed F, Bhuiyan MS, Mostofa MG, et al. (2007) Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli. Infect Immun 75: 2269-2274.
23. Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, et al. (2007) Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhoea of travellers to Guatemala and Mexico. Vaccine 25: 4392-4400.
24. Byrd W, Cassels FJ, (2006) Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres. Vaccine 24: 1359-1366.
25. Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, et al. (2013) Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine 31: 2457-2464.
26. Yu J, Cassels F, Scharton-Kersten T, Hammond SA, Hartman A, et al. (2002) Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect Immun 70: 1056-1068.
27. Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, et al. (2009) Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun 77: 3850-3856.
28. Ahren C, Jertborn M, Svennerholm AM, (1998) Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood. Infect Immun 66: 3311-3316.
29. Salmond RJ, Luross JA, Williams NA, (2002) Immune modulation by the cholera-like enterotoxins. Expert Rev Mol Med 4: 1-16.
30. Alam MM, Arifuzzaman M, Ahmad SM, Hosen MI, Rahman MA, et al. (2013) Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection. Clin Vaccine Immunol 20: 17-23.
31. Ozkul A, Demir B, Karaoglu T, Alkan F, Dincer E, et al. (2008) Maturation of immunoglobulin G avidity after inactive gE deleted bovine herpesvirus type 1 (BHV-1) marker vaccination. Viral Immunol 21: 3-11.
32. Jertborn M, Ahren C, Svennerholm AM, (2001) Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine. Clin Diagn Lab Immunol 8: 424-428.
33. Alam MM, Riyadh MA, Fatema K, Rahman MA, Akhtar N, et al. (2011) Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccine Immunol 18: 844-850.
34. Crotty S, Aubert RD, Glidewell J, Ahmed R, (2004) Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 286: 111-122.
35. Leung DT, Rahman MA, Mohasin M, Patel SM, Aktar A, et al. (2012) Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol 19: 690-698.
36. Gourley TS, Wherry EJ, Masopust D, Ahmed R, (2004) Generation and maintenance of immunological memory. Semin Immunol 16: 323-333.
37. Crotty S, (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29: 621-663.
38. Allen CD, Okada T, Cyster JG, (2007) Germinal-center organization and cellular dynamics. Immunity 27: 190-202.
39. Svennerholm AM, (2011) From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res 133: 188-196.
40. Svennerholm AM, Lundgren A, (2012) Recent progress toward an enterotoxigenic Escherichia coli vaccine. Expert Rev Vaccines 11: 495-507.
41. Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, et al. (2007) Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 75: 3961-3968.
42. Svennerholm AM, Holmgren J, (1995) Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea. Adv Exp Med Biol 371B: 1623-1628.
43. Rudin A, Svennerholm AM, (1994) Colonization factor antigens (CFAs) of enterotoxigenic Escherichia coli can prime and boost immune responses against heterologous CFAs. Microb Pathog 16: 131-139.
44. Darsley MJ, Chakraborty S, DeNearing B, Sack DA, Feller A, et al. (2012) The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol 19: 1921-1931.
45. Lundgren A, Leach S, Tobias J, Carlin N, Gustafsson B, et al. (2013) Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine 31: 1163-1170.
46. Steele D, Riddle M, van de Verg L, Bourgeois L, (2012) Vaccines for enteric diseases: a meeting summary. Expert Rev Vaccines 11: 407-409.